Tumor immune microenvironment in head and neck cancers
- PMID: 32017286
- PMCID: PMC7282929
- DOI: 10.1002/mc.23162
Tumor immune microenvironment in head and neck cancers
Abstract
Head and neck cancers are a heterogeneous group of tumors that are highly aggressive and collectively represent the sixth most common cancer worldwide. Ninety percent of head and neck cancers are squamous cell carcinomas (HNSCCs). The tumor microenvironment (TME) of HNSCCs consists of many different subsets of cells that infiltrate the tumors and interact with the tumor cells or with each other through various networks. Both innate and adaptive immune cells play a crucial role in mediating immune surveillance and controlling tumor growth. Here, we discuss the different subsets of immune cells and how they contribute to an immunosuppressive TME of HNSCCs. We also briefly summarize recent advances in immunotherapeutic approaches for HNSCC treatment. A better understanding of the multiple factors that play pivotal roles in HNSCC tumorigenesis and tumor progression may help define novel targets to develop more effective immunotherapies for patients with HNSCC.
Keywords: cancer immunotherapy; head and neck cancers; tumor microenvironment; tumor-infiltrating lymphocytes.
© 2020 Wiley Periodicals LLC.
Figures
Similar articles
-
Head and neck cancer treatment in the era of molecular medicine.Adv Cancer Res. 2023;160:205-252. doi: 10.1016/bs.acr.2023.03.004. Epub 2023 Apr 12. Adv Cancer Res. 2023. PMID: 37704289 Review.
-
Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma.Int J Mol Sci. 2020 Sep 24;21(19):7032. doi: 10.3390/ijms21197032. Int J Mol Sci. 2020. PMID: 32987799 Free PMC article. Review.
-
Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma.Front Immunol. 2025 May 14;16:1597202. doi: 10.3389/fimmu.2025.1597202. eCollection 2025. Front Immunol. 2025. PMID: 40438103 Free PMC article. Review.
-
Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.Aging (Albany NY). 2020 Nov 18;12(22):22509-22526. doi: 10.18632/aging.103460. Epub 2020 Nov 18. Aging (Albany NY). 2020. PMID: 33216727 Free PMC article.
-
Immunotherapy for Head and Neck Cancer.Hematol Oncol Clin North Am. 2019 Apr;33(2):301-321. doi: 10.1016/j.hoc.2018.12.006. Hematol Oncol Clin North Am. 2019. PMID: 30833002 Review.
Cited by
-
Identification of a novel ceRNA network related to prognosis and immunity in HNSCC based on integrated bioinformatic investigation.Sci Rep. 2022 Oct 20;12(1):17560. doi: 10.1038/s41598-022-21473-0. Sci Rep. 2022. PMID: 36266384 Free PMC article.
-
Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck.J Immunol Res. 2022 Apr 18;2022:5501476. doi: 10.1155/2022/5501476. eCollection 2022. J Immunol Res. 2022. PMID: 35478939 Free PMC article.
-
The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment.Front Immunol. 2023 May 24;14:1189323. doi: 10.3389/fimmu.2023.1189323. eCollection 2023. Front Immunol. 2023. PMID: 37292204 Free PMC article. Review.
-
Immune Cells in Head-and-Neck Tumor Microenvironments.J Pers Med. 2022 Sep 16;12(9):1521. doi: 10.3390/jpm12091521. J Pers Med. 2022. PMID: 36143308 Free PMC article. Review.
-
Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.Int J Mol Sci. 2020 Sep 9;21(18):6585. doi: 10.3390/ijms21186585. Int J Mol Sci. 2020. PMID: 32916850 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424. - PubMed
-
- Llorente JL, López F, Suárez C, Hermsen MA. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nature Reviews Clinical Oncology. 2014;11(8):460–472. - PubMed
-
- Cramer JD, Burtness B, Le QT, Ferris RL. The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol. 2019;16(11):669–683. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical